Analytical Data
-
Gene name
EPSTI1
- Application
-
Alternative Names
EPSTI1;Epithelial-stromal interaction Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96J88
-
Expression Region
1-318aa
-
AA Sequence
MNTRNRVVNS GLGASPASRP TRDPQDPSGR QGELSPVEDQ REGLEAAPKG PSRESVVHAG QRRTSAYTLI APNINRRNEI QRIAEQELAN LEKWKEQNRA KPVHLVPRRL GGSQSETEVR QKQQLQLMQS KYKQKLKREE SVRIKKEAEE AELQKMKAIQ REKSNKLEEK KRLQENLRRE AFREHQQYKT AEFLSKLNTE SPDRSACQSA VCGPQSSTWK LPILPRDHSW ARSWAYRDSL KAEENRKLQK MKDEQHQKSE LLELKRQQQE QERAKIHQTE HRRVNNAFLD RLQGKSQPGG LEQSGGCWNM NSGNSWGI
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EPSTI1, or epithelial serine/threonine kinase 1, is a protein that has garnered interest in biomedical research due to its potential role in cancer biology and cellular signaling pathways. Initially identified as a tumor-associated antigen, EPSTI1 has been found to be overexpressed in various malignancies, indicating its potential as a biomarker for cancer diagnosis and prognosis. Research has shown that EPSTI1 is involved in key cellular processes, including proliferation, apoptosis, and migration, suggesting it may play a pivotal role in tumorigenesis. The recombinant production of EPSTI1 protein provides a valuable tool for studying its structural and functional properties, as well as its interactions with other proteins and cellular components. By generating and characterizing EPSTI1 in a controlled laboratory setting, researchers can explore its mechanisms of action and assess its potential as a therapeutic target. Furthermore, understanding the role of EPSTI1 in the context of cancer progression could pave the way for novel treatment strategies, as therapies aimed at modulating its activity may enhance the effectiveness of existing cancer treatments or provide new avenues for intervention. Overall, the study of recombinant EPSTI1 protein is an important step towards elucidating its biological significance and potential applications in cancer therapy.











